ATE137801T1 - Gegen hiv 1 gp48 spezifische antikörper - Google Patents
Gegen hiv 1 gp48 spezifische antikörperInfo
- Publication number
- ATE137801T1 ATE137801T1 AT89908105T AT89908105T ATE137801T1 AT E137801 T1 ATE137801 T1 AT E137801T1 AT 89908105 T AT89908105 T AT 89908105T AT 89908105 T AT89908105 T AT 89908105T AT E137801 T1 ATE137801 T1 AT E137801T1
- Authority
- AT
- Austria
- Prior art keywords
- specific antibodies
- against hiv
- kda
- hiv
- lymphocytes
- Prior art date
Links
- 208000030507 AIDS Diseases 0.000 abstract 1
- 108010041397 CD4 Antigens Proteins 0.000 abstract 1
- 210000004366 CD4-positive T-lymphocyte Anatomy 0.000 abstract 1
- 241000713772 Human immunodeficiency virus 1 Species 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000003472 neutralizing effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
- C07K16/4216—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-viral Ig
- C07K16/4225—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-viral Ig against anti-HIV Ig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21586788A | 1988-07-06 | 1988-07-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE137801T1 true ATE137801T1 (de) | 1996-05-15 |
Family
ID=22804732
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT89908105T ATE137801T1 (de) | 1988-07-06 | 1989-07-06 | Gegen hiv 1 gp48 spezifische antikörper |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0423198B1 (de) |
JP (1) | JPH03505668A (de) |
AT (1) | ATE137801T1 (de) |
DE (1) | DE68926454T2 (de) |
WO (1) | WO1990000617A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE170559T1 (de) * | 1991-05-31 | 1998-09-15 | Genentech Inc | Behandlung der hiv-assoziierten immun- thrombopenie purpura |
WO1993024647A1 (en) * | 1992-05-22 | 1993-12-09 | Sandoz Ltd. | Anti-idiotypic monoclonal antibodies against the lewis y-specific monoclonal antibody br55-2 and their uses |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE127517T1 (de) * | 1983-04-27 | 1995-09-15 | Harvard College | Verfahren und produkte zur feststellung von menschlichem t-zellen-leukämie-virus. |
US4722888A (en) * | 1985-03-29 | 1988-02-02 | United States Of America As Represented By The Department Of Health And Human Services | Cell line producing human monoclonal antibody which binds to HTLV-I producing cells |
-
1989
- 1989-07-06 DE DE68926454T patent/DE68926454T2/de not_active Expired - Fee Related
- 1989-07-06 EP EP89908105A patent/EP0423198B1/de not_active Expired - Lifetime
- 1989-07-06 WO PCT/US1989/002933 patent/WO1990000617A1/en active IP Right Grant
- 1989-07-06 AT AT89908105T patent/ATE137801T1/de not_active IP Right Cessation
- 1989-07-06 JP JP1507663A patent/JPH03505668A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DE68926454T2 (de) | 1997-01-09 |
JPH03505668A (ja) | 1991-12-12 |
DE68926454D1 (de) | 1996-06-13 |
WO1990000617A1 (en) | 1990-01-25 |
EP0423198A1 (de) | 1991-04-24 |
EP0423198B1 (de) | 1996-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE405679T1 (de) | Synthetische humane neutralisierende monoklonale antikörper gegen hiv | |
EP0345462A3 (de) | Immuntest für HIV-1-Antigene unter Benutzung von F(AB')2-Fragmenten als Sonde | |
ES2113854T3 (es) | Derivados de albumina con funciones terapeuticas. | |
ATE122237T1 (de) | Hiv-1 neutralisierende monoklonale antikörper. | |
NO970221D0 (no) | Humane nöytraliserende monoklonale antistoffer mot humant immunsviktvirus | |
ES2067866T3 (es) | Reactivos inmunologicos que reaccionan con un epitopo constante del virus inmunodeficiente humano del tipo i (vih-1)gp120 y metodos de utilizacion. | |
DK2267452T3 (da) | Opløseligt kompleks omfattende et retroviralt overfladeglycoprotein | |
NO951212L (no) | Humane nöytraliserende monoklonale antistoffer mot humant immunsviktvirus | |
RU94045826A (ru) | Моноклональные антитела против рецептора интерферона, с нейтрализующим действием против интерферона типа i | |
ATE135743T1 (de) | Monoklonale menschliche antikörper gegen hiv-i | |
FI931393A0 (fi) | Peptider foer anvaendning vid vaccinering och induktion av neutraliserande motkroppar mot humant immunbristvirus | |
CA2192512A1 (en) | Nm03 antibody materials and methods | |
DE69128108D1 (de) | Monoklonaler Antikörper gegen HTLV-III (Stamm MN) | |
DE68926454D1 (de) | Gegen hiv 1 gp48 spezifische antikörper | |
ITVR940096A0 (it) | Procedimento ed apparecchiatura per l'immunoadsorbimento specifico di virus hiv, di antigene gp120 e complesso cd4-gp120. | |
KR890700683A (ko) | 인체 면역 결핍 바이러스에 대한 항체 검색 방법 | |
DK1438970T3 (da) | Fremgangsmåde til at inhibere HIV-associerede sygdomme ved hjælp af monoklonale antistoffer rettet mod sig-selv-rettede cytotoksiske celler | |
DE69213325D1 (de) | Gegen das menschliche Immunschwäche-Virus gerichtetes Immunpräparat | |
ATE128733T1 (de) | Monoklonale antikörper gegen hiv gp120. | |
IT7829983A0 (it) | Procedimento per la formazione di pacchi di segnature ed impilatrice per l'esecuzione del procedimento. | |
AU4959193A (en) | High affinity, strongly neutralizing monoclonal antibodies against the CD-4 binding site of GP120 of human immunodeficiency virus | |
ATE184315T1 (de) | Neuartiges endothelzell-molekül, das die bindung von lymphozyten im menschen vermittelt | |
ES2060162T3 (es) | Utilizacion de los anticuerpos monoclonales anti-b2 microglobulina. | |
ATE136469T1 (de) | Neue verwendung eines monoklonalen antikörpers | |
HUP9904262A2 (hu) | Fehérjék alkalmazása retrovírus elleni szerként |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |